Enjoy complimentary customisation on priority with our Enterprise License!
Want to get a preview about how you can gain compelling insights from Technavio’s market research report? Check out the latest facts about the neurotrophic keratitis treatment industry
Neurotrophic keratitis treatment industry growth is expected to accelerate over the next five years, driven by growing geriatric population which will boost the demand for various types of keratopathy treatment. The Americas will drive around 39% of the growth for the global neurotrophic keratitis treatment market, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period. The common treatment options for neurotrophic keratitis include prophylaxis and surgery. Neurotrophic keratitis is related to the alterations in the corneal nerves which results in impairment of sensory and trophic functions with a consequent breakdown of the corneal epithelium. Technavio’s neurotrophic keratitis treatment industry analysis reveals promising markets around the world.
Want a bigger picture? Get a free sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The global neurotrophic keratitis treatment market was dominated by TA product segment with a market share of over 42%, followed by rhNGF and others. TA treatment method is likely to remain dominant in the global neurotrophic keratitis treatment market over the forecast period, while rhNGF and others product segments are forecasted to witness a decline in market share over the next five years. In addition, factors such as advances in technology and rising aged population with affected vision are expected to boost the demand for neurotrophic keratitis treatment over the next few years.
Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial
The global neurotrophic keratitis treatment market is forecasted to grow increasingly concentrated with the existence of a few international and regional vendors who offer keratopathy treatment for neurotrophic keratitis. Most of the established manufacturers in the global neurotrophic keratitis treatment market are focused on evaluation of various phases of drug development for corneal anesthesia and keratopathy treatment for neurotrophic keratitis. Many international and regional vendors are vying for their share of the market, and players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several companies, including:
Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE LANDSCAPE
Drugs under development
PART 08: MARKET SEGMENTATION BY PRODUCT
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.